Navigation Links
ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
Date:1/18/2008

re based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume an obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the prospectus.

ThromboGenics NV

Campus Gasthuisberg

Herestraat 49

B-3000 Leuven

Belgium

Tel: +32(0)16-34-61-94

http://www.thrombogenics.com

BioInvent International AB (publ)

Co. reg. No. 556537-7263,

Address: Solvegatan 41

Mailing address: SE-223 70 LUND

Tel: +46(0)46-286-85-50

info@bioinvent.com

http://www.bioinvent.com

For further information please contact:

ThromboGenics

Prof Desire Collen, CEO

Tel: +32(0)16-34-61-94

desire.collen@thrombogenics.com

Dr. Patrik De Haes, COO

Tel: +32(0)16-34-61-94

patrik.dehaes@thrombogenics.com

Citigate Dewe Rogerson

David Dible / Sylvie Berrebi

Tel: +44(0)207-638-95-71

sylvie.berrebi@citigatedr.co.uk

BioInvent

Svein Mathisen, President & CEO

Tel: +46(0)46-286-85-67

Mob: +46(0)708-97-82-13

svein.mathisen@bioinvent.com

Cristina Glad, Executive Vice President

Tel: +46(0)46-286-85-51

Mob: +46(
'/>"/>

SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
2. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
3. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
4. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
5. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
6. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
7. Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
8. Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
9. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
10. Genta Receives Notice of Non-Compliance With NASDAQ Rule
11. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...wswire/ -- The Eniva Research Group has,released r...Linus Pauling,Micronutrient Research Institute at ...va Health Supplement VIBE(R) possessed DNA protect...third party testing was,performed as part of an on...hanisms by which the Eniva VIBE nutraceutical impa...
(Date:7/3/2008)...wire/ - OncoGenex Technologies Inc. and Isis,Pharm...that the companies,have amended their agreement an...ts lead cancer drug OGX-011. Under the amended agr...ture development activities,costs and partnering ...be,responsible for funding 35% of development cost...
(Date:7/3/2008)...RNewswire-FirstCall/ -- AMDL, Inc. (Amex:,ADL), a ...tered in Tustin,Ca., with operations in Shenzhen,... released its investor presentation which is avail...://www.amdl.com ., About AMDL:, AMDL, Inc. is a ...ny is,headquartered in Tustin, California with ope...
(Date:7/2/2008)...ing Stent to Demonstrate Superiority Over,Market-L...United States for Treatment of Co.../- Abbott today,announced t...proved the,XIENCE(TM) V Everolimus Eluting Coronar...y disease. XIENCE V is the only drug eluting stent...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2OncoGenex increases economic interest in lead cancer drug OGX-011 2OncoGenex increases economic interest in lead cancer drug OGX-011 3OncoGenex increases economic interest in lead cancer drug OGX-011 4AMDL Announces Investor Relations Presentation Available on Website 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5
...gene Corp. will appeal the jury verdict that Madis...alifornia company last week. , ,Stratagene on Satu...n rendered last Wednesday in the United States Dis... The jury awarded Third Wave $5.29 million in da...t "believes that the jury,s verdict and the damage...
...ference comes together , there,s always one or two...own right, but for one reason or another, they jus...aunch at DEMO. , ,One such company is Nutrihand ,...ex-Microsofter Soraya Bittencort, Mountain View, C...ased service that helps diabetics and their health...
...stics has selected RedPrairie Corp.,s DLx Labor ... productivity and customer service throughout its ...sday. DCS Logistics , with corporate offices in D...e solution at all of its logistics centers. , ,DS...panies such as Kellogg,s, Unilever, Yamaha, Georgi...
...entative measures, Katrina caught many businesses ...ofessor James Carlini, what disaster recovery plan...d your home and how updated are they? , ,While mo...and residential aspects, few reports have really t...inesses down in the South. , ,They already have sa...
Other Biology Technology:Stratagene to appeal verdict won by Third Wave 2The one that got away 2The one that got away 3Hurricane Katrina: Many disaster recovery systems were outdated 2Hurricane Katrina: Many disaster recovery systems were outdated 3Hurricane Katrina: Many disaster recovery systems were outdated 4
(Date:7/2/2008)...specter of a worldwide outbreak of avian or "bird ...drugs are desperately needed since some strains of...e current roster of anti-flu remedies. , Now, a ... resources at the San Diego Supercomputer Center (...han two dozen promising and novel compounds from w...
(Date:7/2/2008)... at North Carolina State University have found tha... if there is an abrasion, providing insight into p... or individuals involved in the manufacturing of q...cal applications of the tiny nanoparticles. , W...t sizes, shapes and surface coatings do not penetr...
(Date:7/2/2008)...se is available in German . , Metabolomics aims...of a cell or a tissue. The exponents of bioinforma... pre-clinical metabolomics study in healthy and di...ls was treated with the diabetes drug Roziglitazon...tively determined in a blood plasma sample of a to...
(Date:7/2/2008)...o. In the first study of its kind, using sophistic...onally known commercial weight loss program, Weigh...s to find out which method wins in the game of goo...ined the real-life experiences of participants to ...reduce body fat and gain health benefits. The answ...
Breaking Biology News(10 mins):UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 2UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 3UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 4Study shows quantum dots can penetrate skin through minor abrasions 2Healthy or diseased? 2Weight Watchers vs. fitness centers 2VAs My HealtheVet Honored for 22Consumer Empowerment 22 8864 1VAs My HealtheVet Honored for 22Consumer Empowerment 22 8864 2Schering Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference 2396 1Schering Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference 2396 2Uninsured Benefit Once They Are Covered by Medicare 8861 1Uninsured Benefit Once They Are Covered by Medicare 8861 2Uninsured Benefit Once They Are Covered by Medicare 8861 3Uninsured Benefit Once They Are Covered by Medicare 8861 4High Blood Triglycerides Linked to Stroke Risk 8859 1High Blood Triglycerides Linked to Stroke Risk 8859 2
...ed by biologists at the University of California, ...that makes them susceptible to Bacillus thuringien...cteria and widely used by organic farmers and in g...ts. , Their findings should facilitate the design...e researchers believe also possess the molecule, f...
... to inheritance laws the scientific world has acce...o normal traits carried by their grandparents, byp...ts. , These mutant parent plants apparently have h...m the preceding generation that can be transferred... evident in the parents, according to Purdue Unive...
...ers here have used a new microscopic, three-dimens...sform themselves into fat cells, and then to funct... body. , While other studies have previously grown...e cells never completely functioned in the same wa... the genetic and biologic components that all cell...
... up to 75 percent of breast cancer,patients have a...,drugs that target different molecules along that...the disease, says a researcher from,The University...rer picture is now emerging,about the importance o... to breast cancer development, says Gordon Mills, ...
Other Biology News:UCSD discovery may help extend life of natural pesticide 2UCSD discovery may help extend life of natural pesticide 3Plants defy Mendel's inheritance laws, may prompt textbook changes 2Plants defy Mendel's inheritance laws, may prompt textbook changes 3Tiny scaffolding allows stem cells to become working fat cells 2Tiny scaffolding allows stem cells to become working fat cells 3
Mouse monoclonal [2D7/1] to E.coli LPS ( Abpromise for all tested applications). Antigen: Tissue / cell preparation: Escherichia coli J5 cells.
Request Info
Vesicle Associated Membrane Protein (VAMP 1/2)
Human / Porcine Endothelin 1 from AnaSpec
Biology Products: